Given our preliminary evidence showing that VEGFR2 stimulated ROS overproduction, the current study aims at investigating whether PSPC alleviates kidney injury by downregulating VEGFR2-mediated oxidation stress and inflammation and further explaining the pathological mechanism underlying kidney damage in HFD-treated mice. This evidence concerns the gene KDR and medical procedure.